Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) feasibility randomised controlled trial in four European primary care settings

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 600 人开始时间: 2014年5月7日最近更新: 2019年3月18日

适应症

试验速览

•1. Registered with a participating practice
•2. Age 40 ? 60 on date of consent
•3. Presence of any one (or more) of the following risk factors
•3.1. Depression ? previous history OR active episode of minor depression as recorded on medical record ? IF GP deems patient fit to participate
•3.2. Diabetes (diagnosis e.g. on a diabetes disease register)
•3.3. Hypertension (as per national guidelines)
•3.4. Obesity (BMI of 30.0 or above)
•3.5. Current smoker
•3.6. High cholesterol (as per national guidelines)
•3.7. Coronary heart disease (diagnosis e.g. on a CHD disease register)
•3.8. Self reported sedentary lifestyle
•3.9. Self reported lack of cognitive stimulation
•4. Medically stable
•5. Literate in language of the partner country where patient is recruited (English/Dutch/French as appropriate).
•6. Access to the internet in order to communicate by email and access information online

•1. Active episode of major depression, if GP deems patient too severely ill to participate, recorded in medical record or assessed using a validated assessment score e.g. HADS
•2. People who are unable to give informed consent
•3. People who have dementia

发起方

HS Greater Glasgow and Clyde (UK)